Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,209.01
(
1.02%
)
US TECH 100
26,736.40
(
1.03%
)
Dow Jones
49,652.14
(
1.62%
)
Brent Oil
111.00
(
0.59%
)
Bitcoin
77,412.00
(
1.42%
)
News Focus
News Focus
Post# of 257473
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

dewophile

Send PM Follow Ignore
Followers 50
Posts 5533
Boards Moderated 0
Alias Born 07/19/2006

dewophile

Re: DewDiligence post# 256342

Sunday, 11/09/2025 2:31:09 PM

Sunday, November 09, 2025 2:31:09 PM

Post# of 257473
PFE / ENTA /SNY

I just got around to reading the PFE transcript and in response to a question about a new oral phase 2 drug they admitted it is indeed a stat6 inhibitor that was previously in stealth mode. This puts them about even with KYMR and ahead of the SNY partnered program and ENTA


https://s206.q4cdn.com/795948973/files/doc_events/2025/Nov/04/PFE-USQ_Transcript_2025-11-04.pdf

KYMR has a market cap of 4B largely on the back of their stat6 program
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today